Keywords: chugai, abgenix, forge, mab, alliance, usa, japan

Chugai and Abgenix forge MAb alliance

Article | 10 February 2003

Abgenix of the USA and Japan's Chugai Pharmaceutical have entered intoa collaboration to develop and commercialize fully-human monoclonal antibody therapies ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Chugai Pharmaceutical

Go to company listing